Zuranolone: A Game-Changer for Postpartum Depression Treatment │PHARMACOLOGY

In this video, we delve into the groundbreaking medication zuranolone and its revolutionary impact on treating postpartum depression (PPD). Zuranolone is a fast-acting neuroactive steroid that targets the brain's GABA receptors, offering rapid relief from PPD symptoms. Join us as we explore the science behind how it works, its efficacy in clinical trials, and how it differs from traditional antidepressants.
Disclaimer: This CZcams channel is not intended to provide diagnosis, treatment, or medical advice. The content provided in this video is for informational purposes only. This should not be considered as a substitute for advice from a healthcare professional. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options. The statements made about specific products are not to diagnose, treat, cure, or prevent disease.
References
1. www.fda.gov/news-events/press...
2. Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial [published correction appears in JAMA Psychiatry. 2022 Jul 1;79(7):740] [published correction appears in JAMA Psychiatry. 2023 Feb 1;80(2):191]. JAMA Psychiatry. 2021;78(9):951-959. doi:10.1001/jamapsychiatry.2021.1559
3. Deligiannidis KM, Meltzer-Brody S, Maximos B, et al. Zuranolone for the Treatment of Postpartum Depression. Am J Psychiatry. 2023;180(9):668-675. doi:10.1176/appi.ajp.20220785
#DepressionTreatment #MentalHealAwareness #Mentalhealthresearch #neuropharmacology #pharmacology #medicaleducation #medicationexplained #pharmacologymadeeasy